# Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

> **NCT03932136** · PHASE3 · RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 300 (estimated)

## Conditions studied

- Clinical High Risk Syndrome of Psychosis

## Interventions

- **DIETARY_SUPPLEMENT:** Sulforaphane
- **COMBINATION_PRODUCT:** Placebo

## Key facts

- **NCT ID:** NCT03932136
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-07-14
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932136, "Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03932136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*